These results indicated that co-treatment of AMG with gemcitabine increased mitochondrial ROS production in CCA, partly mediated by the downregulation of Sirt1/Nrf2 signaling by AMG. This evidence concerns the gene NFE2L2 and cholangiocarcinoma.